HC | IgGOB− | IgGOB+ | |
---|---|---|---|
Gender (F/M) | 13/4 | 9/5 | 17/9 |
Age at LP (years) | 43.2 ± 9.2 | 37.2 ± 10.7 | 38.2 ± 9.7 |
Disease duration (years) | n.a. | 0.3 ± 0.6 | 0.6 ± 1.1 |
Csf-[Alb] (mg/dL) | 17.0 ± 5.1 | 21.2 ± 8.7 | 23.1 ± 10.4 |
S-[Alb] (mg/dL) | 4370.6 ± 379.0 | 4225.0 ± 297.7 | 4278.8 ± 355.6 |
QAlb (10−3) | 3.9 ± 1.2 | 5.0 ± 2.0 | 5.4 ± 2.4* |
Csf-[IgG] (mg/dL) | 2.2 ± 0.9 | 2.4 ± 0.8 | 4.5 ± 1.8**** °°°° |
S-[IgG] (mg/dL) | 1141.2 ± 215.2 | 944.6 ± 124.2** | 1094.3 ± 211.6° |
QIgG (10−3) | 1.9 ± 0.6 | 2.6 ± 1.0 | 4.2 ± 1.8**** °° |
IgG Index | 0.5 ± 0.1 | 0.5 ± 0.1 | 0.8 ± 0.3**** °°° |
IgG Loc (mg/dL) | 0.1 ± 0.3 | 0.2 ± 0.6 | 9.0 ± 11.5** ° |
IgIF (%) | 0 ± 0 | 1.1 ± 2.7 | 16.4 ± 18.5*** °° |
Leukocyte counts (/μL) | 2.1 ± 1.1 | 2.9 ± 2.4 | 9.0 ± 8.6*** ° |
Csf -[BAFF] (pg/mL) | 67.3 ± 21.6 | 69.9 ± 27.3 | 50.7 ± 20.5* ° |
BAFF Index | 17.5 ± 5.2 | 13.2 ± 5.1 | 11.9 ± 6.1** |
Csf-[CXCL13] (pg/mL) | 0.9 ± 1.5 | 5.0 ± 8.2 | 27.7 ± 33.5*** ° |
Csf-[IL21] (pg/mL) | 28.1 ± 29.1 | 21.6 ± 25.3 | 20.2 ± 21.9 |